Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CytoCore, a clinical diagnostics company, and Synermed Select Partners, a provider of clinical laboratory products and services, have signed a distribution agreement that gives CytoCore US and international rights to distribute the Synermed general cytology preservative in combination with its SoftPAP cervical cell collection device.
Subscribe to our email newsletter
According to CytoCore, the SoftPAP cervical cell collector offers quicker, more accurate specimen collection with minimal possibility of user error. It is designed to consistently sample the entire cervix in a single-step using an inflatable balloon collector.
Robert McCullough, Jr, CEO of CytoCore, said: This agreement with Synermed allows CytoCore to offer physicians and laboratories the Synermed Preservative with our SoftPAP cervical cell collector in one convenient, cost-effective package. We believe the combination of SoftPAP and the Synermed products provide tremendous benefit to women patients, doctors and diagnostic laboratories. We are excited about introducing ‘the combination kit’ internationally where both products are approved.
Synermed Select Partners is a privately held company that is focused upon the development, manufacture and introduction of instruments and reagents for use in diagnostics and clinical chemistry tests and provides clinical reference laboratory services, clinical laboratory management and consulting services.
CytoCore develops screening systems for early detection of gynecological and other cancers. The company’s pipeline product CytoCore Solutions System is being developed to provide medical practitioners with highly accurate, low-cost, screening systems for cervical and other cancers that can be seamlessly integrated into existing medical models